Cargando…
Perioperative Administration of Emend(®) (Aprepitant) at a Tertiary Care Children’s Hospital: A 12-Month Survey
INTRODUCTION: Aprepitant (Emend(®)) is a novel antiemetic agent that works through antagonism of neurokinin-1 (NK-1) receptors. To date, there are limited data regarding its use to prevent postoperative nausea and vomiting (PONV) in children. We retrospectively reviewed our initial 12-months experie...
Autores principales: | Kanaparthi, Anuradha, Kukura, Sarah, Slenkovich, Natalie, AlGhamdi, Faris, Shafy, Shabana Z, Hakim, Mohammed, Tobias, Joseph D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885572/ https://www.ncbi.nlm.nih.gov/pubmed/31819673 http://dx.doi.org/10.2147/CPAA.S221736 |
Ejemplares similares
-
A Survey to Define and Predict Difficult Vascular Access in the Pediatric Perioperative Population
por: Hakim, Mohammed, et al.
Publicado: (2020) -
Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases
por: Arends, Jordan, et al.
Publicado: (2020) -
Characterization of the Difficult Peripheral IV in the Perioperative Setting: A Prospective, Observational Study of Intravenous Access for Pediatric Patients Undergoing Anesthesia
por: Heydinger, Grant, et al.
Publicado: (2022) -
The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013) -
Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)